January 4, 2018 / 5:49 PM / Updated 7 minutes ago BRIEF-Foamix Announces Positive Results From Late Stage Acne Treatment Study Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Foamix Pharmaceuticals Ltd: 
* FOAMIX ANNOUNCES POSITIVE RESULTS FROM PHASE 3 OPEN-LABEL SAFETY EXTENSION EVALUATING FMX-101 TOPICAL MINOCYCLINE FOAM FOR TREATMENT UP TO 1 YEAR Source text for Eikon: Further company coverage: